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t has long been thought that it is not possible
to prevent the onset of mental disorders, because the
processes involved in the etiology are too complex and
not yet sufficiently understood. In the past 15 years, how-
ever, the knowledge about identifying target groups for
prevention and about the effects of preventive inter-
ventions has increased considerably. A growing number
of randomized controlled trials has shown that it is pos-
sible in some cases to actually prevent or at least delay
the onset of mental disorders, including depressive dis-
orders and anxiety disorders, and some studies indicate
that it may even be possible to prevent the onset of psy-
chotic disorders in high-risk groups (see review below). 
Research on effective prevention programs is very
important for several reasons. First, effective prevention
programs may potentially contribute to the reduction of
the enormous burden of mental disorders.
1 Mental dis-
orders account for 22% of the total burden of disease in
established market economies, as measured in disability-
adjusted life years lost,
2 with the common mental disor-
ders (depression, anxiety, and substance use disorders)
accounting for three quarters of the burden of all mental
disorders. At any given moment, 150 million people suf-
fer from a depressive disorder, 90 million suffer from a
substance-related disorder, and each year a million peo-
ple commit suicide. Mental disorders are associated with
huge losses in quality of life in patients and their relatives,
with increased mortality and morbidity, with high levels
of service use, and with enormous economic costs.
3,4
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In the past 15 years a considerable number of studies
have found evidence that it may be possible to prevent
the onset of some mental disorders. Most evidence is
available for depressive disorders, but a growing num-
ber of studies have focused on anxiety disorders and
psychotic disorders. This paper reviews the studies which
have examined the effects of preventive interventions
on the incidence of mental disorders in people who do
not meet criteria for a mental disorder at baseline. More
than 20 studies have examined prevention of depressive
disorders, and they have found an overall reduction in
the incidence of about 25% compared with control
groups. The problem of identifying the most optimal
target groups for preventive interventions is also illus-
trated. This is a problem because most risk indicators
have a low specificity, and most people with a risk indi-
cator do not develop a mental disorder. Finally, this
paper will show how other statistics, such as the expo-
sure rate, the attributable fraction, and the number
needed to treat can help in identifying the most opti-
mal target groups for preventive interventions. 
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DCNS_43_4.qxd:DCNS#43  1/12/09  23:59  Page 447It is estimated that only half of the burden of the com-
mon mental disorders can be averted with existing treat-
ment methods (both psychological and pharmacologi-
cal) given maximized coverage (the number of people
seeking treatment), clinician competence, and patient
compliance with treatment.
5 If we want to reduce the
burden of mental disorders further, we can either
develop new treatment methods that are considerably
better than existing ones, or we can develop preventive
interventions that result in reductions of new cases. The
option for preventive interventions has not been exam-
ined very thoroughly, although it can be regarded as a
promising way to reduce the burden of psychiatric dis-
eases.
5Another reason why this research is so important
is that it may increase our knowledge of the etiology of
mental disorders. Until now, most mental disorders have
been thought to be caused by multiple factors on differ-
ent levels (physical, social, psychological), and it is not
possible to predict which individual is going to develop
the disorder and who is not. If it proves to be possible to
prevent new cases of mental disorders, the interventions
must somehow change the basic mechanisms that lead
to the occurrence of the disorder. 
This review will first define exactly what prevention is.
Then, the research on the effects of interventions on the
prevention of the incidence of new cases of mental dis-
orders will be summarized. Finally, the possibilities of
developing personalized preventive interventions, using
new epidemiological methods to identify the most
important high-risk groups for prevention, will be
described.
What is prevention?
In the definition of depression which is currently used
by most researchers and practitioners, depression com-
prises all interventions which are conducted before sub-
jects meet the formal criteria for a mental disorder
(according to the Diagnostic and Statistical Manual of
Mental Disorders. 4th ed, DSM-IV).
6 Curative interven-
tions are given to persons who suffer from acute disor-
ders, and maintenance treatments are given to patients
with chronic disorders. In this spectrum of interventions,
three types of prevention can be distinguished:
￿ Universal prevention is aimed at the general popula-
tion or parts of the general population, regardless of
whether they have a higher-than-average risk of devel-
oping a disorder. The best-known examples of univer-
sal prevention include school programs aimed at all
students, whether they have an increased risk of devel-
oping a mental disorder or not, and mass-media cam-
paigns, aimed at the general population. 
￿ Selective prevention is aimed at high-risk groups, who
have not yet developed a mental disorder. High-risk
groups include people who have recently experienced
a stressful life event or who experience a chronic stres-
sor, such as divorce, losing a family member through
death, caring for an ill family member, and unemploy-
ment.
￿ Indicated prevention is aimed at individuals who have
some symptoms of a mental disorder but do not meet
diagnostic criteria. Indicated prevention is aimed at
people who already suffer from some (depressive)
symptoms.
Is prevention of mental disorders effective?
In the past few decades, several hundred controlled stud-
ies have examined the effects of mental health programs
aimed at preventing mental health problems at school,
7,8
substance use and abuse at school,
9 work-related stress,
10
distress among caregivers for the elderly,
11,12 child
abuse,
13–15 and many other conditions. This considerable
body of research has shown that some prevention pro-
grams in mental health are capable of strengthening pro-
tective factors, such as social skills, problem-solving skills,
stress-management skills, prosocial behavior, and social
support; that these programs can reduce the conse-
quences of risk factors, psychiatric symptoms, and sub-
stance use; and that they may have positive economic
effects. 
However, only a small proportion of these studies have
focused on possibilities for actually preventing the onset
of new cases of mental disorders.
6 In recent years, a
growing number of studies have examined whether pre-
vention programs are actually capable of reducing the
incidence of cases of mental disorders as defined by
diagnostic criteria. In these studies a standardized diag-
nostic interview at baseline is used to exclude the pretest
presence of a full-blown depressive disorder and to
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up (again with a diagnostic interview). In the following,
we will review these studies.
Prevention of depressive disorders
Most research has focused on the prevention of depres-
sive disorders. Following the first studies conducted in
the 1990s,
16-18 the number of studies has increased
rapidly since 2000. We recently conducted a meta-analy-
sis of these studies,
19 and found a total of nineteen stud-
ies in which subjects with a depressive disorder accord-
ing to DSM criteria at baseline were excluded, and only
subjects with no formal depressive disorder were
included. All these studies examined whether the inci-
dence rate of mental disorders was reduced in the recip-
ients of preventive interventions compared with sub-
jects who did not participate in such an intervention. We
found that the overall incidence rate ratio was 0.78
(95% CI: 0.65~0.93). The incidence rate ratio is the inci-
dence rate of developing a depressive disorder in exper-
imental subjects relative to the incidence rate in control
subjects. An incidence rate ratio of 0.78 indicates a
reduction of the risk of developing a depressive disor-
der in the next year of about 22% compared with peo-
ple in the control groups. This study indicates that pre-
vention of new cases of depressive disorders is indeed
possible, and could be a realistic strategy to reduce the
enormous burden of these disorders, next to treatment
of existing depressive disorders. Preventive interven-
tions have been developed in several settings, including
the school setting, prevention of postpartum depression
in pregnant women, and prevention of depression in
general medical disorders. 
A considerable number of studies has examined the pos-
sibilities of prevention in the school setting.
20,21 However,
most of these have only examined whether school pro-
grams are capable of reducing the overall level of
depressive symptoms in students. Although this is inter-
esting in its own right, and positive effects may be indica-
tive of effects on depressive disorders, the results of
these studies do not result in clear evidence of a pre-
ventive effect of these interventions on depressive dis-
orders. Until now, only four studies have examined pre-
ventive interventions aimed at the reduction of the
incidence of depressive disorders at school.
17,22-24 Two
studies used a universal intervention aimed at all stu-
dents, regardless of whether they had an increased risk
of developing a depressive disorder.
25,26 In both studies,
no significant effect on the onset of depressive disorders
was found. In three studies, the effects of an indicated
intervention were used examined,
17,22,24 and these had
mixed results, with one study finding strong and signifi-
cant effects on the incidence of new depressive disorders
at 1-year follow-up.
17 Most interventions in the school
setting, both universal and indicated, have used cogni-
tive behavioral group interventions. 
There is also a considerable number of studies that have
examined the possibilities of preventing postpartum
depression (PPD),
27,28 but again most of these studies did
not use diagnostic criteria at pretest and post-test, to
exclude women who already had a depressive disorder
at pretest, and to examine the effects of prevention on
the incidence. Most studies have used self-report mea-
sures, and have only examined whether the level of
depressive symptoms have decreased in the prevention
groups compared with control groups. Many of these
studies used cognitive behavioral interventions,
29-30
although other studies used psychoeducational inter-
ventions,
31 debriefing,
32 and interpersonal psychother-
apy.
33,34A recent meta-analysis of studies on prevention
of PPD did not find clear evidence that preventive inter-
ventions during pregnancy may reduce the incidence of
postpartum depression.
27 This meta-analysis did not,
however, focus on studies in which women who met
diagnostic criteria for a depressive disorder were
excluded at pretest, and in which the incidence of
depression in treatment and control groups were estab-
lished according to diagnostic criteria. In the earlier
described meta-analysis, seven randomized controlled in
which diagnostic instruments were used, could be
included. These resulted in an incidence rate ratio of 0.65
(95% CI: 0.41~1.05; P<0.1).
Another group of studies has focused on the prevention
of depression in general medical disorders. Several
groups of general medical patients have been examined
in prevention studies, including adolescents with newly
diagnosed epilepsy and subthreshold depression (but no
major depressive disorder),
35 older patients with neo-
vascular macular degeneration,
36 and stroke patients.
37
Three studies have examined the possibility of prevent-
ing depressive disorders in primary care.
16,38,39 Most stud-
ies in this field used cognitive behavior therapy
16,35,38 or
problem-solving therapy as intervention.
36,37
One of the studies in primary care used a stepped-care
intervention. Such stepped-care interventions are inter-
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gle interventions (with a reduction of the incidence of
50%),
39 and because they devote most intervention time
to those who need it most. In such a stepped-care
approach, the first step is watchful waiting. This means
that no specific intervention is conducted for 6 to 8
weeks, because many subclinical depressive symptoms
recover spontaneously without intervention. In the sec-
ond step, a guided self-help intervention is provided to
patients. Guided self-help has been proven to be effec-
tive in the reduction of depressive symptoms,
40 and may
be sufficient for some patients. If the guided self-help is
not sufficient and patients continue to have depressive
symptoms, a brief psychological intervention is provided,
such as problem-solving therapy, or a brief cognitive-
behavioral intervention. When this is not enough,
patients are referred to specialized mental health care
where they receive intensive treatment with antidepres-
sant medication.
Prevention of other mental disorders
Although most research has examined the effect of pre-
vention on the incidence of depressive disorders, a grow-
ing number of studies has examined the possibilities of
preventing the onset of anxiety disorders and psychotic
disorders in high-risk populations.
A considerable number of studies has examined the pos-
sibility of preventing the onset of post-traumatic stress
disorder (PTSD) with debriefing interventions.
41
Unfortunately, many of these studies did not use diag-
nostic instruments to establish the presence of PTSD at
follow-up. However, the studies that have been con-
ducted seem to indicate that debriefing increases the risk
of developing PTSD, instead of decreasing this risk.
41,42
Several other studies have examined the possibilities of
prevention of other anxiety disorders. In an early study
among patients with panic attacks who visited the emer-
gency room of a hospital, it was found that exposure
therapy had better outcomes than reassuring them that
there was no physical illness.
43 In a more recent study
among persons with high levels of anxiety sensitivity, it
was found that preventive training consisting of psy-
choeducation and behavioral exercises significantly
reduced the risk of developing an anxiety disorder in the
following 2 years.
44 In another study, it was found that
the incidence of panic disorder in people with sub-
threshold panic attacks is lower at 6 months' follow-up
in those who attended a 1-day preventive workshop
compared with those on a waiting list.
45
In recent years, several studies have examined the effects
of preventive interventions on the onset of psychotic dis-
orders.
46-49 In these studies, patients with subthreshold
symptoms of psychotic disorders (without meeting full
diagnostic criteria) are randomized to cognitive behav-
ior therapy or a control condition. These studies show
significant reductions of transition to psychotic episodes
in those who have received the preventive interventions,
compared with those in the control groups, although the
longer-term effects are not so clear.
47,48
Problems in identifying target groups for pre-
ventive interventions
In the preceding paragraphs it was shown that a consid-
erable number of recent studies have examined the
effects of preventive interventions on the incidence of
mental disorders, and, when taken together, with con-
siderable success. However, the success of these inter-
ventions depends very much on the selection of the right
target populations. The first step in every intervention is
to select a target population which has an increased risk
of developing a mental disorder within the coming
months or year. In the following paragraphs, we will
explain why this selection of high-risk groups is very
complicated, and present some recently developed
methods in epidemiology to solve the problems in the
selection of target groups.
In the past few decades, an enormous body of research
has shown that many biological, psychological, and psy-
chosocial risk indicators are associated with the onset of
mental disorders. These include genetic factors, charac-
teristics of personality, social economic status, stress and
burden, urbanization, loneliness, life events, and somatic
factors, such as complications during pregnancy, devel-
opmental disorders, neuroendocrinological factors, and
general medical disorders. Note that we define these vari-
ables as risk indicators, and not as risk factors, as risk fac-
tors suggest that these are causally associated with the
onset of depressive disorders. Risk indicators only indi-
cate that there is an association between the variable and
the onset, while no causal association is assumed. In prin-
ciple, these risk indicators can be used to identify target
groups for preventive interventions. In the next part of
this paper, we will show that several groups of interven-
tions actually have focused on such high-risk groups.
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ated with the onset of mental disorders, most of them
have a low specificity. This low specificity implies that
most subjects who are exposed to the risk factor do not
develop the disorder, and that one such risk factor by
itself is not sufficient to bring the disorder into being.
50,51
Furthermore, most risk indicators are related to lifetime
risk, while target populations for preventive interven-
tions must have an increased risk at the shorter term.
Suppose, for example, that the risk of developing a major
depressive disorder in the general population is 2.5% in
1 year.
52,53 If a high-risk group has a relative risk of devel-
oping a depressive disorder of 4.00, this will be highly
significant (if the research population is large enough).
However, this means that still only about 10% of the
high-risk group will actually develop a depressive disor-
der, and about 90% will not. 
Many epidemiological researchers are satisfied after
finding a highly significant relative risk of 4.00, but from
the point of view of prevention this is clearly not
enough. A high-risk group will probably be difficult to
motivate for participation in a preventive program if
only 10% eventually will develop the disorder, apart
from the question of whether it is ethically acceptable to
identify such a population as being “at risk” when most
are in fact not at risk, or to intervene in such a popula-
tion when for the vast majority of participants the inter-
vention is not needed, and thus the time they spend on
it is, in a sense, wasted. Furthermore, such an interven-
tion is probably not very efficient or cost-effective,
because the majority will never develop a disorder and
the intervention has no preventive effect in this major-
ity. 
From the perspective of preventive intervention
research, this low specificity is also problematic because
very large numbers of subjects are needed to provide
sufficient statistical power for these intervention stud-
ies.
51 Suppose, for example, that we would be able to
motivate people from the high-risk group (10% of
whom will develop a mental disorder in the following
year) to participate in a preventive intervention. In order
to show that such an intervention is capable of reducing
the incidence from 10% to 5% (a risk reduction of
50%), we would need about 950 persons in a controlled
trial (assuming a statistical power of 0.80; alpha level
0.05; calculations in STATA/SE 8.2). Trials of this size are
logistically complex, expensive, and have a high risk of
failure.
Towards an improved method of identifying
target groups for prevention
As previously stated, traditional indicators of the
strength between a risk indicator and the incidence of a
mental disorder are not sufficient when we want to iden-
tify the best target populations for preventive interven-
tions and to develop personalized interventions.
Improvements can be made by selecting target groups
while using indices other than odds ratios (ORs), rela-
tive risks (RRs) or incidence rate ratios (IRRs) alone,
and in particular by studying the cumulative effect of
joint exposures to several risk indicators rather than the
effect of a single risk indicator. The proposed method
can be carried out in several steps.
First, a set of significant risk indicators is identified such
that each of them has a statistically significant impact on
the likelihood that the disorder will develop. To do this
any of the available measures of association for binary
outcomes (OR, RR or IRR) can be used.
Second, if an OR can be calculated, then it is also possi-
ble to say how many people are exposed to that risk
indicator. Call this measure “exposure rate” (ER). For
prevention the ER is important, because it tells us how
many people have to be targeted by the preventive
intervention. Clearly, smaller groups (smaller ER) are
associated with less effort and hence lower costs of deliv-
ering the intervention.
Third, with the OR and ER in hand one can calculate
the population attributable fraction (AF). The AF indi-
cates by how many percent points the current incidence
rate of the mental disorder in the population could be
reduced when the adverse effect of the risk indicator is
completely blocked.
54-56This equals the maximum possi-
ble health gain of a completely successful preventive
intervention.
Fourth, if the OR can be calculated, then it is also possi-
ble to obtain the risk difference (eg, under a linear prob-
ability model) and its inverse: the number needed to
treat (NNT). In the context of these analyses the NNT
can be interpreted as the number of people who should
be the recipients of a preventive intervention to avoid
the onset of the disorder in one person. Again we have
to assume that the preventive intervention is completely
successful in containing the adverse effect of the risk fac-
tor. This assumption is not realistic, but the NNT may
still help to create a hierarchy of risk indicators to be tar-
geted in prevention.
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want to maximize the health gain (large AF) and mini-
mize the effort to generate this health gain by targeting
the smallest possible group (small ER) in the most effi-
cient way (small NNT). Best values overall can be found
by looking at combinations of risk indicators. That is, we
can see what combinations of exposures (joint expo-
sures) help to minimize and maximize the indices, such
that a target group is selected where prevention is most
likely to become cost-effective. 
There are several ways of finding specific combinations
of risk indicators, whether genetic or environmental, that
meet the above criteria, including sophisticated statisti-
cal techniques, such as classification and regression trees
(CART) analysis, and bootstrap aggregation (bag-
ging).
57,58The most straightforward method, which we use
here for illustrative purposes, is to select significant pre-
dictors of incidence (with standard techniques such as
logistic regression) after which all possible combinations
of these significant risk indicators are explored in terms
of maximizing the OR and AF, and minimizing ER and
NNT associated with each of the joint exposures. We
used this approach in a population-based sample of
older adults,
54 and found that subjects with (subclinical)
depressive symptoms, functional limitations, a small
social network, and female gender comprised only 8%
of the total population (ER) while 24.2% of the new
incident cases could be attributed to this group (AF).
The number of subjects from this population that would
have to receive a preventive intervention in order to pre-
vent one incident case (NNT) was 4 (assuming that the
intervention is 100% successful). 
There is little doubt that these methods will help to iden-
tify the best target groups for preventive interventions
in the near future and to develop personalized inter-
ventions. However, at this moment these methods have
not yet been applied in intervention studies. 
Conclusion
This paper is intended to illustrate why prevention of
mental disorders is important. Reasons for its impor-
tance include its very high prevalence, incidence, disease
burden, and its huge economic costs of depression. It is
also important because current treatments can reduce
the disease burden only to a limited extent, even when
only evidence-based treatments are given and all
patients receive such an intervention. 
In the past 15 years a growing number of studies has
shown that interventions to prevent the onset of depres-
sive disorders are probably effective, and can reduce the
incidence by about one quarter. Prevention of anxiety
disorders and psychotic disorders may also be effective,
although the number of studies in these areas are lower.
It is not clear whether these preventive interventions
have actually prevented the onset of mental disorders
altogether, or only delayed the onset. In both cases, how-
ever, the health benefits of preventive interventions are
considerable.
In the next few years, the internet will probably provide
new opportunities for the broad implementation of pre-
ventive interventions, because access is easy, cheap, and
effective. Another important development is stepped-
care interventions, which are interesting because they
may have stronger effects than individual interventions
and spend most resources on those who need it most.
It has also been shown that traditional epidemiological
research can not identify the best target populations for
prevention. Relatively simple statistics, such as the expo-
sure rate, the population attributable fraction, and the
number needed to treat can be used to select those high-
risk groups which are as small as possible, but explain as
many of the new incident cases as possible. These meth-
ods will probably help in the further development of
personalized preventive interventions. ❏
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La prevención: un objetivo alcanzable en la
medicina personalizada
En los últimos quince años numerosos estudios han
encontrado evidencias de que puede ser posible
prevenir la aparición de algunos trastornos menta-
les. Si bien la mayor evidencia de que se dispone
corresponde a los trastornos depresivos, existe un
número creciente de estudios focalizados en los
trastornos de ansiedad y psicóticos. Este artículo
revisa los estudios que han examinado los efectos
de las intervenciones preventivas en la incidencia
de los trastornos mentales en personas que no cum-
plen con los criterios de un trastorno mental en el
estado basal. Más de veinte estudios han exami-
nado la prevención de los trastornos depresivos, y
han encontrado una reducción global de la inci-
dencia de alrededor del 25% comparado con los
grupos control. También se ilustra el problema de
la identificación de los grupos blanco más especí-
ficos para realizar intervenciones preventivas. Esto
es un problema porque la mayoría de los indicado-
res de riesgo tienen una baja especificidad, y la
mayor parte de las personas con un indicador de
riesgo no desarrolla un trastorno mental. Por
último, este artículo muestra cómo otras variables
(frecuencia de exposición, fracción atribuible y
número necesario para tratar) pueden ayudar a
identificar los grupos blanco más específicos para
las intervenciones preventivas.
La prévention : un objectif accessible pour la
médecine personnalisée
Un nombre important d’études a montré au cours
de ces 15 dernières années qu’il pourrait être pos-
sible de prévenir la survenue de certains troubles
mentaux. La plupart des résultats concernait les
troubles dépressifs mais de plus en plus d’études se
sont intéressées aux troubles anxieux et psycho-
tiques. Cet article passe en revue les études qui ont
examiné les effets des actions de prévention sur l’in-
cidence des troubles mentaux chez des sujets qui ne
présentaient pas initialement les critères de patho-
logies psychiatriques. Dans plus de 20 études ana-
lysant la prévention des troubles dépressifs, l’inci-
dence a globalement diminué d’environ 25 %
comparée aux groupes témoins. Il est difficile
d’identifier les meilleurs groupes cibles pour les
actions préventives car la plupart des indicateurs de
risque ont une faible spécificité et la plupart des
personnes ayant un indicateur de risque ne déve-
loppent pas de maladie mentale. Enfin, cet article
se propose de montrer comment d’autres variables
statistiques, comme le taux d’exposition, la fraction
attribuable et le nombre de sujets ayant besoin
d’être traités peuvent aider à identifier les cibles les
plus adaptées des interventions de prévention..
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